Detalhe da pesquisa
1.
Management of Breast Cancer Survivors by Gynecologists.
Clin Obstet Gynecol
; 65(3): 494-509, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35708967
2.
Patient and provider factors associated with the noninitiation of tamoxifen for young women at high-risk for the development of breast cancer.
Breast J
; 26(3): 464-468, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31538708
3.
When Should Prophylactic Oophorectomy Be Recommended at the Time of Elective Hysterectomy?
Clin Obstet Gynecol
; 63(2): 337-348, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31876638
4.
Foreword: Management of Breast Disorders.
Clin Obstet Gynecol
; 65(3): 427-429, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35703227
5.
Health Disparities in Ovarian Cancer: Report From the Ovarian Cancer Evidence Review Conference.
Obstet Gynecol
; 142(1): 196-210, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37348095
6.
Executive Summary of the Ovarian Cancer Evidence Review Conference.
Obstet Gynecol
; 142(1): 179-195, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37348094
7.
Phosphorylation of elongation factor-2 kinase differentially regulates the enzyme's stability under stress conditions.
Biochem Biophys Res Commun
; 424(2): 308-14, 2012 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22749997
8.
Cancer genetics and breast cancer.
Best Pract Res Clin Obstet Gynaecol
; 82: 3-11, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35272929
9.
Health Disparities in Uterine Cancer: Report From the Uterine Cancer Evidence Review Conference.
Obstet Gynecol
; 139(4): 645-659, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35272301
10.
Executive Summary of the Uterine Cancer Evidence Review Conference.
Obstet Gynecol
; 139(4): 626-643, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35272316
11.
Inhibition of eEF-2 kinase sensitizes human glioma cells to TRAIL and down-regulates Bcl-xL expression.
Biochem Biophys Res Commun
; 414(1): 129-34, 2011 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21945617
12.
Integrated regulation of autophagy and apoptosis by EEF2K controls cellular fate and modulates the efficacy of curcumin and velcade against tumor cells.
Autophagy
; 9(2): 208-19, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23182879
13.
Identification of Sirtuin 3, a mitochondrial protein deacetylase, as a new contributor to tamoxifen resistance in breast cancer cells.
Biochem Pharmacol
; 86(6): 726-33, 2013 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23856293
14.
Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death.
PLoS One
; 7(4): e35104, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22496897
15.
MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis.
Mol Cancer Ther
; 11(1): 154-64, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22057914
16.
Differential gene expression in tamoxifen-resistant breast cancer cells revealed by a new analytical model of RNA-Seq data.
PLoS One
; 7(7): e41333, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22844461
17.
Dysfunction of nucleus accumbens-1 activates cellular senescence and inhibits tumor cell proliferation and oncogenesis.
Cancer Res
; 72(16): 4262-75, 2012 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22665267